AR125853A2 - PHARMACEUTICAL COMPOSITION OF A HEMISULPHATE SALT OF A NUCLEOTIDE COMPOUND - Google Patents

PHARMACEUTICAL COMPOSITION OF A HEMISULPHATE SALT OF A NUCLEOTIDE COMPOUND

Info

Publication number
AR125853A2
AR125853A2 ARP220101263A ARP220101263A AR125853A2 AR 125853 A2 AR125853 A2 AR 125853A2 AR P220101263 A ARP220101263 A AR P220101263A AR P220101263 A ARP220101263 A AR P220101263A AR 125853 A2 AR125853 A2 AR 125853A2
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
nucleotide compound
hemisulphate salt
salt
hemisulphate
Prior art date
Application number
ARP220101263A
Other languages
Spanish (es)
Inventor
Adel Moussa
Jean-Pierre Sommadossi
Original Assignee
Atea Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atea Pharmaceuticals Inc filed Critical Atea Pharmaceuticals Inc
Publication of AR125853A2 publication Critical patent/AR125853A2/en

Links

Abstract

Composición farmacéutica de una sal hemisulfato de un nucleótido de fórmula (1).Pharmaceutical composition of a hemisulfate salt of a nucleotide of formula (1).

ARP220101263A 2017-02-01 2022-05-12 PHARMACEUTICAL COMPOSITION OF A HEMISULPHATE SALT OF A NUCLEOTIDE COMPOUND AR125853A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762453437P 2017-02-01 2017-02-01
US202062469912P 2020-03-10 2020-03-10
US202062488366P 2020-04-21 2020-04-21
US202062575248P 2020-10-20 2020-10-20

Publications (1)

Publication Number Publication Date
AR125853A2 true AR125853A2 (en) 2023-08-16

Family

ID=87886881

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220101263A AR125853A2 (en) 2017-02-01 2022-05-12 PHARMACEUTICAL COMPOSITION OF A HEMISULPHATE SALT OF A NUCLEOTIDE COMPOUND

Country Status (1)

Country Link
AR (1) AR125853A2 (en)

Similar Documents

Publication Publication Date Title
CO2020014586A2 (en) Compounds
AR101995A1 (en) INTEGRINA AVB6 ANTAGONIST COMPOUNDS
AR111304A1 (en) METHODS FOR SYNTHESIZING AN MCL-1 INHIBITOR
ECSP17054980A (en) SELECTIVE BACE1 INHIBITORS
AR098870A1 (en) Polymorphic forms of a chlorohydrate salt of (S) -2- (1- (9H-PURIN-6-ILAMINO) PROPIL) -5-FLUORO-3-PHENYLQUINAZOLIN-4 (3H) -ONA
EA202091500A1 (en) Pyrazole N-Bonded Carbamoylcyclohexyl Acids as LPA Antagonists
EA201591634A1 (en) DIHYDROPYRIDOPYRIMIDINE COMPOUNDS
EA201792021A1 (en) JAK INHIBITOR
EA202091505A1 (en) Triazolazoles of Cyclohexyl Acid as LPA Antagonists
RS54730B1 (en) Inhibitors of beta-secretase
EA202193015A1 (en) CDK INHIBITORS
CL2018001067A1 (en) Pyranodipyridine compound.
CL2020000376A1 (en) Pentacyclic compound.
EA201591915A1 (en) COMPOUNDS OF PHENOXYETHYL DIHYDRO-1H-IZOHINOLINA
AR105821A1 (en) USEFUL COMPOUNDS TO INHIBIT ROR-g-T
MY193239A (en) Novel b-lactamase inhibitors
EA201990238A1 (en) Phosphorus-containing stimulants of sGC stimulants
MX2018004055A (en) Imino compounds with a 2-chloropyrimidin-5-yl substituent as pest-control agents.
EA201990313A1 (en) DERIVATIVE TRIAZOLOPYRAZINONE USED AS A HUMAN PDE1 INHIBITOR
AR110770A1 (en) POTASSIUM CHANNEL MODULATORS
AR104241A1 (en) THIAZINE TETRAHYDROFIDE DERIVATIVES AS SELECTIVE BACE1 INHIBITORS
AR125853A2 (en) PHARMACEUTICAL COMPOSITION OF A HEMISULPHATE SALT OF A NUCLEOTIDE COMPOUND
EA201791596A1 (en) PYRAZOL COMPOUNDS
EA201791098A1 (en) METHOD FOR SYNTHESIS OF BENZAZEPIN DERIVATIVES
AR115865A2 (en) THERAPEUTIC COMPOUNDS